E. Premkumar Reddy is a molecular biologist specialising in molecular oncology. He is the Director of Experimental Cancer Therapeutics program and Professor in the Departments of Oncological Sciences and Structural and Chemical Biology at the Mount Sinai School of Medicine.
The Beatson West of Scotland Cancer Centre is a specialised cancer care centre in Glasgow, Scotland. Until recently it had facilities in Gartnavel General Hospital, the Western Infirmary and Glasgow Royal Infirmary. As part of the NHS Greater Glasgow and Clyde Acute Services Review, the centre is being centralised within new facilities at the Gartnavel General Hospital site.
Rakesh K. Jain is the Andrew Werk Cook Professor of Tumor Biology at Massachusetts General Hospital in the Harvard Medical School and Director of the E.L. Steele Laboratories for Tumor Biology at the Massachusetts General Hospital.
John Gordon McVie was an international authority on the treatment and research of cancer. He wrote over 350 peer-reviewed articles, editorials and books. McVie was born in Glasgow, Scotland and died of non-Hodgkin lymphona and COVID-19 in Bristol, England.
Harald zur Hausen NAS EASA APS is a German virologist and professor emeritus. He has done research on cervical cancer and discovered the role of papilloma viruses in cervical cancer, for which he received the Nobel Prize in Physiology or Medicine 2008.
Clinical Cancer Research is a peer-reviewed medical journal on oncology, including the cellular and molecular characterization, prevention, diagnosis, and therapy of human cancer, medical and hematological oncology, radiation therapy, pediatric oncology, pathology, surgical oncology, and clinical genetics. The applications of the disciplines of pharmacology, immunology, cell biology, and molecular genetics to intervention in human cancer are also included. One of the main interests of Clinical Cancer Research is on clinical trials that evaluate new treatments together with research on pharmacology and molecular alterations or biomarkers that predict response or resistance to treatment. Another priority for Clinical Cancer Research is laboratory and animal studies of new drugs as well as molecule-targeted agents with the potential to lead to clinical trials, and studies of targetable mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease. The journal is published by the American Association for Cancer Research.
The International Journal of Oncology is a monthly peer-reviewed medical journal of oncology, published by Spandidos Publications. It was established in 1992 and the editor-in-chief is Demetrios A. Spandidos. According to the Journal Citation Reports, the journal has a 2020 impact factor of 5.650.
John E. Niederhuber, MD was the 13th director of the National Cancer Institute (NCI), from 2006 until July, 2010, succeeding Andrew von Eschenbach, who went on to become a director at biotechnology firm BioTime. A nationally renowned surgeon and researcher, Dr. Niederhuber has dedicated his four-decade career to the treatment and study of cancer - as a professor, cancer center director, National Cancer Advisory Board chair, external advisor to the NCI, grant reviewer, and laboratory investigator supported by NCI and the National Institutes of Health. He is now Executive Vice President/CEO Inova Translational Medicine Institute and Inova Health System and co-director, Johns Hopkins Clinical Research Network.
Sir Bruce Anthony John Ponder FMedSci FAACR FRS is an English geneticist and cancer researcher. He is Emeritus Professor of Oncology at the University of Cambridge and former director of the Cancer Research UK Cambridge Institute and of the Cancer Research UK Cambridge Cancer Centre.
Clara Derber Bloomfield, was an American physician and cancer researcher. Her work focused on the genetic changes that are present in certain types of blood cancers, and how those can be utilized to improve treatment for the affected patients.
Clement Adebamowo is a Nigerian medical researcher and academic. Born in Lagos, Nigeria, Adebamowo is currently Director For Global Health Cancer Research, and a professor of Epidemiology & Public Health, at the University of Maryland School of Medicine. He is known for his work in cancer epidemiology, nutrition epidemiology, and research ethics, particularly in low resource and under-served in Africa.
Paul Workman, is a British scientist noted for his work on the discovery and development of pharmaceutical agents in the field of oncology. He is President and CEO of The Institute of Cancer Research In London.
Giorgio Stassi is an Italian scientist.
Janet S Butel is the Chairman and Distinguished Service Professor in the molecular virology and microbiology department at Baylor College of Medicine. Her area of expertise is on polyomavirus pathogenesis of infections and disease. She has more than 120 publications on PubMed. She also has 6 publications in Nature, which is considered one of the most prestigious science journals. She is a member of 9 different organizations and has 13 honors and awards.
Oncology Letters is a monthly peer-reviewed medical journal covering all aspects of oncology. It was established in 2010 and is published by Spandidos Publications. The editor-in-chief is Demetrios Spandidos. According to the Journal Citation Reports, the journal has a 2022 impact factor of 3.11, ranking it 97th out of 211 journals in the category "Oncology".
Margaret Frame is Professor of Cancer Biology and Science Director of Cancer Research Centre at the University of Edinburgh. She is also Director of MRC Institute of Genetics & Molecular Medicine. She has made seminal contributions to understanding mechanisms of cell adhesion and motility. She previously served as deputy-director of the Beatson Institute in Glasgow.
Richard Malcolm Marais is Director of the Cancer Research UK (CRUK) Manchester Institute and Professor of Molecular Oncology at the University of Manchester.
Anne Greenough is a British neonatologist and is most notable for research into clinical and academic neonatology through work relating to the origins, markers and management of chronic lung disease following preterm birth. Greenough is Professor of Neonatology and Clinical Respiratory Physiology at King's College London.
The University of Glasgow’s Glasgow Precision Oncology Laboratory (GPOL) is a molecular research facility that partners with the NHS and industry to perform research into the development of novel therapeutic strategies, the creation of pan-cancer genomic assays and provide knowledge transfer for healthcare systems to enable them to develop landscapes for therapeutic testing in cancer.
